Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
19 10 2021
Historique:
received: 22 03 2021
accepted: 18 08 2021
pubmed: 4 9 2021
medline: 3 11 2021
entrez: 3 9 2021
Statut: ppublish

Résumé

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a global effort to rapidly develop and deploy effective and safe coronavirus disease 2019 (COVID-19) vaccinations. Vaccination has been one of the most effective medical interventions in human history, although potential safety risks of novel vaccines must be monitored, identified, and quantified. Adverse events must be carefully assessed to define whether they are causally associated with vaccination or coincidence. Neurologic adverse events following immunizations are overall rare but with significant morbidity and mortality when they occur. Here, we review neurologic conditions seen in the context of prior vaccinations and the current data to date on select COVID-19 vaccines including mRNA vaccines and the adenovirus-vector COVID-19 vaccines, ChAdOx1 nCOV-19 (AstraZeneca) and Ad26.COV2.S Johnson & Johnson (Janssen/J&J).

Identifiants

pubmed: 34475124
pii: WNL.0000000000012703
doi: 10.1212/WNL.0000000000012703
pmc: PMC8548963
doi:

Substances chimiques

Ad26COVS1 JT2NS6183B
COVID-19 Vaccines 0
Measles-Mumps-Rubella Vaccine 0
Poliovirus Vaccines 0
ChAdOx1 nCoV-19 B5S3K2V0G8

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

767-775

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS105935
Pays : United States

Informations de copyright

© 2021 American Academy of Neurology.

Références

Lancet Infect Dis. 2013 Sep;13(9):769-76
pubmed: 23810252
Trans R Soc Trop Med Hyg. 1988;82(3):472-5
pubmed: 2906768
Neurology. 2014 Nov 11;83(20):1823-30
pubmed: 25320099
Vaccine. 2015 Jul 17;33(31):3636-49
pubmed: 26073015
PLoS One. 2012;7(3):e33536
pubmed: 22470453
Calif Med. 1947 Jun;66(6):360-3
pubmed: 18731238
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Nature. 2020 Oct;586(7830):516-527
pubmed: 32967006
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):784-789
pubmed: 32584798
Sci Transl Med. 2015 Jul 1;7(294):294ra105
pubmed: 26136476
J Neurol. 2011 Mar;258(3):500-1
pubmed: 20878418
J Transl Int Med. 2019 Dec 31;7(4):137-142
pubmed: 32010599
EBioMedicine. 2019 Feb;40:595-604
pubmed: 30711515
PLoS One. 2012;7(3):e33723
pubmed: 22470463
Vaccine. 2019 Oct 3;37 Suppl 1:A94-A98
pubmed: 30150166
Lancet. 1998 Feb 28;351(9103):637-41
pubmed: 9500320
Neurology. 1987 Apr;37(4):550-6
pubmed: 2436091
MMWR Recomm Rep. 2000 May 9;49(RR-5):1-22; quiz CE1-7
pubmed: 15580728
Expert Rev Vaccines. 2012 May;11(5):609-28
pubmed: 22827246
Emerg Infect Dis. 2006 Jan;12(1):29-33
pubmed: 16494713
Br J Ophthalmol. 1999 Oct;83(10):1200-1
pubmed: 10636652
Clin Infect Dis. 1999 Oct;29(4):855-61
pubmed: 10589903
Pediatrics. 2002 Nov;110(5):957-63
pubmed: 12415036
MMWR Morb Mortal Wkly Rep. 2020 Apr 24;69(16):489-495
pubmed: 32324719
Rev Inst Med Trop Sao Paulo. 1998 Sep-Oct;40(5):295-9
pubmed: 10030074
J Travel Med. 2008 Jan-Feb;15(1):58-9
pubmed: 18217872
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004407
pubmed: 16235361
Curr Top Microbiol Immunol. 2009;333:43-82
pubmed: 19768400
Pediatrics. 2000 Dec;106(6):1307-17
pubmed: 11099582
Eur J Pediatr. 1996 Feb;155(2):136-8
pubmed: 8775230
Bull World Health Organ. 2000;78(5):693-8
pubmed: 10859864
JAMA. 1994 May 25;271(20):1602-5
pubmed: 8182813
Am J Epidemiol. 1979 Aug;110(2):105-23
pubmed: 463869
Sleep Med Rev. 2018 Apr;38:177-186
pubmed: 28847694
Clin Exp Immunol. 2012 Sep;169(3):199-204
pubmed: 22861358
Vaccine. 2015 Jul 17;33(31):3773-8
pubmed: 25999283
J Med Case Rep. 2018 Nov 30;12(1):356
pubmed: 30497512
J Infect Dis. 1997 Feb;175 Suppl 1:S176-82
pubmed: 9203713
Cochrane Database Syst Rev. 2020 Apr 20;4:CD004407
pubmed: 32309885
J Infect Dis. 2014 Nov 1;210 Suppl 1:S368-72
pubmed: 25316857
Front Immunol. 2019 Mar 27;10:594
pubmed: 30972078
Neurology. 2019 Sep 24;93(13):584-594
pubmed: 31462584
JAMA. 2012 Jul 11;308(2):175-81
pubmed: 22782419
MMWR Morb Mortal Wkly Rep. 1997 Jan 31;46(4):79-83
pubmed: 9048844
Pediatr Neurol. 2000 Aug;23(2):177-9
pubmed: 11020647
Vaccine. 2015 Jun 26;33(29):3288-92
pubmed: 26004568
N Engl J Med. 1987 Feb 12;316(7):369-74
pubmed: 2433582
Vaccine. 2009 May 5;27(20):2649-52
pubmed: 19428874
Vaccine. 2018 Oct 1;36(41):6202-6211
pubmed: 30122647
JAMA. 2004 Jul 21;292(3):351-7
pubmed: 15265850
Cureus. 2020 Sep 2;12(9):e10208
pubmed: 33033684

Auteurs

Kiran Teresa Thakur (KT)

From the Department of Neurology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York. ktt2115@cumc.columbia.edu.

Samantha Epstein (S)

From the Department of Neurology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York.

Amanda Bilski (A)

From the Department of Neurology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York.

Alanna Balbi (A)

From the Department of Neurology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York.

Amelia K Boehme (AK)

From the Department of Neurology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York.

Thomas H Brannagan (TH)

From the Department of Neurology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York.

Sarah Flanagan Wesley (SF)

From the Department of Neurology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York.

Claire S Riley (CS)

From the Department of Neurology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH